IQVIA

Sr Medical Safety Advisor

Tokyo, Japan

$120,000 – $160,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalIndustries

Requirements

Candidates should possess PV and risk management expertise, a strong understanding of international safety regulations and guidelines, and the ability to maintain knowledge of product, product environment, and recent literature. They must also be capable of leading cross-functional Safety Management Teams and communicating effectively with internal and external stakeholders, including Health Authorities and key opinion leaders.

Responsibilities

The Sr Medical Safety Advisor will provide PV and risk management expertise to internal and external customers, conduct signal detection and analysis, support due diligence activities and pharmacovigilance agreements, lead aggregate safety data review activities, and coordinate safety surveillance activities. Additionally, they will identify and implement proactive safety analysis strategies, collaborate with Center of Excellence groups, and participate in safety governance processes.

Skills

PV
Risk Management
International Safety Regulations
Signal Detection
Pharmacovigilance
Data Review
Safety Surveillance
Stakeholder Communication

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Key Metrics

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI